Apellis Pharmaceuticals, Inc. is now owned by ProShare Advisors LLC (NASDAQ:APLS)
According to the most recent report that ProShare Advisors LLC submitted to the Securities and Exchange Commission, during the third quarter of 2018, the company …
According to the most recent report that ProShare Advisors LLC submitted to the Securities and Exchange Commission, during the third quarter of 2018, the company …
Stock According to the most recent 13F filing that Yards Bank & Trust Co. submitted with the Securities and Exchange Commission, the company’s holdings in …
Lisanti Capital Growth LLC increased its position in Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) during the third quarter by 52.3%, as stated in the most recent …